Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-006959
Filing Date
2025-09-10
Accepted
2025-09-10 17:31:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3223
  Complete submission text file 0001950047-25-006959.txt   4761
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Subject) CIK: 0000876343 (see all company filings)

EIN.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-12830 | Film No.: 251306698
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 1300 N. KELLOGG DRIVE SUITE D ANAHEIM CA 92607
Business Address
BAILEY DON M (Reporting) CIK: 0001223697 (see all company filings)

Type: 144